SECO 2022 in review: findings presented in New Orleans

SECO hosted its 2022 annual meeting March 9-13 at the Ernest N. Morial Convention Center with a LIVE CE virtual meeting available to online attendees.

The Southeastern Congress of Optometry (SECO) conference was held in New Orleans, Louisiana from March 9-13, 2022 at the Ernest N. Morial Convention Center, with a virtual platform available to online attendees.



Glaucoma

Glaucoma: More pressures than meet the eye

Other factors, besides IOP, can contribute to glaucomatous optic nerve damage

Interventional glaucoma management: The art and science

Lee Peplinski, OD, FAAO, emphasizes the importance of interventional care in patients with glaucoma.

Co-managing glaucoma in 2022: The OD/MD angle

Mitch Ibach, OD, FAAO and Michael Greenwood, MD review their SECO 2022 presentation on comanaging glaucoma



Retina

Retina news: What's hot (and not)

Mohammad Rafieetary, OD, FAAO, offers a sneak peek at the latest (and fake!) news in retina.

Significance of imaging in retinal disease scans

Mohammad Rafieetary, OD, FAAO, shares highlights from his SECO 2022 presentation titled "Image-in that! Scanning for retinal disease."



Dry eye

Adding intense pulsed light to your practice

Selina McGee, OD, FAAO, disscusses her SECO 2022 presentation "See the light! Adding IPL to your practice."

Combatting dry eye during contact lens wear

Tools and therapies for dry eye with contact lens wear

The ocular surface and makeup: What you need to know

Pamela Theriot OD, FAAO, on highlights from her SECO 2022 presentation "Makeup and the ocular surface: what you need to know"



Optometry

Managing myopia with orthokeratology

Kelly Voltz, OD, FAAO, FSLS, on highlights from her presentation "Ortho-K" during the 2022 SECO meeting.

Amblyopia management: A new paradigm

Robert Sanet, OD, explains the new paradigm in amblyopia, or lazy eye, management

Focusing on giant cell arteritis and optic neuritis

Clinical pearls on giant cell arteritis (GCA) and optic neuritis

Focus on amblyopia, thyroid eye disease, and papilledema

Clinical pearls on amblyopia, thyroid eye disease, and papilledema treatments from SECO 2022.


ASCO, Johnson & Johnson Vision partner for more diversity in optometry

The unique partnership and corresponding sponsorship is the largest in ASCO’s history.

Augmenting corneal thickness with FDA-approved hypotonic riboflavin

Daniel Fuller, OD, FAAO Dipl., FSLS, discusses augmenting corneal thickness in thin keratoconus corneas during corneal cross-linking via FDA-approved hypotonic riboflavin during SECO 2022.

Effective treatments for presbyopia, myopia, demodex

Pipeline treatments for presbyopia, myopia, and demodex are expanding rapidly